Geron (GERN) Change in Receivables (2024 - 2026)
Geron's (GERN) quarterly Change in Receivables came in at $8.9 million in Q2 2026, up 67.6% year-over-year from $5.3 million in Q2 2025, and up 82.63% quarter-over-quarter from $4.9 million in Q1 2026.
Analysis
Geron (GERN) Change in Receivables (2024 - 2026) Analysis & Trends
Geron has disclosed Change in Receivables across 3 years of filings, most recently posting $8.9 million for Q2 2026.
- In Q2 2026, Change in Receivables rose 67.6% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $14.1 million (down 60.18% YoY), while the FY2025 annual figure was $991000.0, down 97.22% from the prior year.
- Change in Receivables came in at $8.9 million for Q2 2026 at Geron, up from $4.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $27.1 million in Q3 2024 to a low of -$4.6 million in Q1 2025.
- Average Change in Receivables over 3 years is $5.6 million, with a median of $4.9 million recorded in 2026.
- The largest YoY upside for Change in Receivables was 510.18% in 2025 against a maximum downside of 104.69% in 2025.
- Over 3 years, Change in Receivables stood at $7.7 million in 2024, then slumped by 79.45% to $1.6 million in 2025, then jumped by 465.7% to $8.9 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $8.9 million in Q2 2026, $4.9 million in Q1 2026, and $1.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | 8.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.94 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | 5.33 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Jun 30, 2024 | 874,000.00 |